West Pharmaceutical Services Receivables 2010-2024 | WST

West Pharmaceutical Services receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • West Pharmaceutical Services receivables for the quarter ending September 30, 2024 were $0.524B, a 1% increase year-over-year.
  • West Pharmaceutical Services receivables for 2023 were $0.512B, a 0.91% increase from 2022.
  • West Pharmaceutical Services receivables for 2022 were $0.507B, a 3.76% increase from 2021.
  • West Pharmaceutical Services receivables for 2021 were $0.489B, a 26.91% increase from 2020.
West Pharmaceutical Services Annual Receivables
(Millions of US $)
2023 $512
2022 $507
2021 $489
2020 $385
2019 $319
2018 $288
2017 $253
2016 $201
2015 $181
2014 $179
2013 $186
2012 $175
2011 $147
2010 $126
2009 $139
West Pharmaceutical Services Quarterly Receivables
(Millions of US $)
2024-09-30 $524
2024-06-30 $479
2024-03-31 $524
2023-12-31 $512
2023-09-30 $519
2023-06-30 $534
2023-03-31 $513
2022-12-31 $507
2022-09-30 $485
2022-06-30 $528
2022-03-31 $499
2021-12-31 $489
2021-09-30 $476
2021-06-30 $481
2021-03-31 $466
2020-12-31 $385
2020-09-30 $373
2020-06-30 $341
2020-03-31 $333
2019-12-31 $319
2019-09-30 $316
2019-06-30 $331
2019-03-31 $318
2018-12-31 $288
2018-09-30 $303
2018-06-30 $297
2018-03-31 $290
2017-12-31 $253
2017-09-30 $252
2017-06-30 $242
2017-03-31 $225
2016-12-31 $201
2016-09-30 $210
2016-06-30 $219
2016-03-31 $210
2015-12-31 $181
2015-09-30 $195
2015-06-30 $199
2015-03-31 $190
2014-12-31 $179
2014-09-30 $196
2014-06-30 $210
2014-03-31 $209
2013-12-31 $186
2013-09-30 $198
2013-06-30 $195
2013-03-31 $189
2012-12-31 $175
2012-09-30 $183
2012-06-30 $185
2012-03-31 $176
2011-12-31 $147
2011-09-30 $153
2011-06-30 $166
2011-03-31 $161
2010-12-31 $126
2010-09-30 $143
2010-06-30 $146
2010-03-31 $147
2009-12-31 $139
2009-09-30 $143
2009-06-30 $143
2009-03-31 $137
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49